Research Topic

Recent Dopamine Imaging in Psychiatry

About this Research Topic

Dopaminergic neurotransmission is of main interest in the pathophysiology of psychiatric disorders such as mood, substance use, and psychotic disorders. Numerous studies have revealed alterations of molecules contributing to dopaminergic neurotransmission, including dopamine D2/3 receptors (D2/3Rs), D1 receptors (D1Rs), transporters (DAT) and dopamine synthesis. Although in vivo molecular neuroimaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) have been standards for quantification of these molecules, imaging modalities such as neuromelanin (NM), functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) have also been recently employed in the estimation of dopamine neurotransmission. These modalities can indirectly measure changes in dopamine neurotransmission in brain regions implicated in the pathophysiology of psychiatric disorders.
The goal of this Research Topic is to collect findings from recent dopamine neuroimaging studies focusing on the pathophysiology of psychiatric disorders, as well as pharmacological/non-pharmacological treatment, in particular, intervention by psychotropic agents and neuromodulation such as electro-convulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS).
We welcome original research articles, reviews, meta-analysis and perspective papers investigating:
• Novel dopamine neuroimaging techniques in patients with psychiatric disorders.
• Reproducibility of novel dopamine neuroimaging techniques in healthy individuals
• Changes in measurements of dopaminergic neurotransmission with conventional dopamine neuroimaging modalities by pharmacological/non-pharmacological intervention.
• Pharmacological fMRI studies on dopamine neurotransmission.
• Neuromelanin MRI and diffusion tensor imaging studies on dopaminergic neurotransmission system.
• Specific versus transdiagnostic changes of dopaminergic neurotransmission
• Multimodal imaging of dopaminergic neurotransmission


Keywords: Dopamine Neuroimaging, Psychiatric Disorders, Repetitive Transcranial Magnetic Stimulation, Electroconvulsive Therapy Psychotropic Drugs


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Dopaminergic neurotransmission is of main interest in the pathophysiology of psychiatric disorders such as mood, substance use, and psychotic disorders. Numerous studies have revealed alterations of molecules contributing to dopaminergic neurotransmission, including dopamine D2/3 receptors (D2/3Rs), D1 receptors (D1Rs), transporters (DAT) and dopamine synthesis. Although in vivo molecular neuroimaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) have been standards for quantification of these molecules, imaging modalities such as neuromelanin (NM), functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) have also been recently employed in the estimation of dopamine neurotransmission. These modalities can indirectly measure changes in dopamine neurotransmission in brain regions implicated in the pathophysiology of psychiatric disorders.
The goal of this Research Topic is to collect findings from recent dopamine neuroimaging studies focusing on the pathophysiology of psychiatric disorders, as well as pharmacological/non-pharmacological treatment, in particular, intervention by psychotropic agents and neuromodulation such as electro-convulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS).
We welcome original research articles, reviews, meta-analysis and perspective papers investigating:
• Novel dopamine neuroimaging techniques in patients with psychiatric disorders.
• Reproducibility of novel dopamine neuroimaging techniques in healthy individuals
• Changes in measurements of dopaminergic neurotransmission with conventional dopamine neuroimaging modalities by pharmacological/non-pharmacological intervention.
• Pharmacological fMRI studies on dopamine neurotransmission.
• Neuromelanin MRI and diffusion tensor imaging studies on dopaminergic neurotransmission system.
• Specific versus transdiagnostic changes of dopaminergic neurotransmission
• Multimodal imaging of dopaminergic neurotransmission


Keywords: Dopamine Neuroimaging, Psychiatric Disorders, Repetitive Transcranial Magnetic Stimulation, Electroconvulsive Therapy Psychotropic Drugs


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

23 July 2021 Abstract
22 October 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

23 July 2021 Abstract
22 October 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..